• Grail published a medical research presentation on real-world diagnostic workups following positive Galleri multi-cancer early detection blood tests.
• The retrospective claims analysis identified cancer in 150 of 285 patients (52.6%) within 360 days of a positive result.
• Patients without identified cancer averaged 0.70 invasive procedures, versus 1.25 among those with cancer.
• Imaging use was similar, averaging 1.17 procedures without identified cancer versus 1.25 with cancer.
• Diagnostic workups aligned with predicted cancer signal origins, supporting practical implementation in clinical settings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief on October 25, 2026, and is solely responsible for the information contained therein.